Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)
Clinical trial NCT04635423 · COMPLETED
Trial details
- NCT number
- NCT04635423
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2023-12-31
- Enrollment
- 1059
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.